Sleep Disturbance in Psoriatic Disease: Prevalence and Associated Factors

REFERENCES

1. 1.↵
   1. Boehncke WH,
   2. Schön MP

   . Psoriasis. Lancet 2015;386:983–94.

   OpenUrlCrossRefPubMed
2. 2.↵
   1. Christophers E

   . Psoriasis—epidemiology and clinical spectrum. Clin Exp Dermatol 2001;26:314–20.

   OpenUrlCrossRefPubMed
3. 3.↵
   1. Rachakonda TD,
   2. Schupp CW,
   3. Armstrong AW

   . Psoriasis prevalence among adults in the United States. J Am Acad Dermatol 2014;70:512–6.

   OpenUrlCrossRefPubMed
4. 4.↵
   1. Gladman DD,
   2. Antoni C,
   3. Mease P,
   4. Clegg DO,
   5. Nash P

   . Psoriatic arthritis: epidemiology, clinical features, course, and outcome. Ann Rheum Dis 2005;64:ii14–17.
5. 5.↵
   1. Gladman DD

   . Psoriatic arthritis. Dermatol Ther 2009;22:40–55.

   OpenUrlCrossRefPubMed
6. 6.↵
   1. Husted JA,
   2. Gladman DD,
   3. Farewell VT,
   4. Cook RJ

   . Health-related quality of life of patients with psoriatic arthritis: A comparison with patients with rheumatoid arthritis. Arthritis Care Res 2001;45:151–8.

   OpenUrlCrossRef
7. 7.↵
   1. Hayes J,
   2. Koo J

   . Psoriasis: depression, anxiety, smoking, and drinking habits. Dermatol Ther 2010;23:174–80.

   OpenUrlCrossRefPubMed
8. 8.↵
   1. Gupta MA,
   2. Gupta AK

   . Depression and suicidal ideation in dermatology patients with acne, alopecia areata, atopic dermatitis and psoriasis. Br J Dermatol 1998;139:846–50.

   OpenUrlCrossRefPubMed
9. 9.↵
   1. Callis Duffin K,
   2. Wong B,
   3. Horn EJ,
   4. Krueger GG

   . Psoriatic arthritis is a strong predictor of sleep interference in patients with psoriasis. J Am Acad Dermatol 2009;60:604–8.

   OpenUrlPubMed
10. 10.↵
    1. Wu Y,
    2. Mills D,
    3. Bala M

    . Psoriasis: cardiovascular risk factors and other disease comorbidities. J Drugs Dermatol 2008;7:373–7.

    OpenUrlPubMed
11. 11.↵
    1. Strober BE,
    2. Sobell JM,
    3. Duffin KC,
    4. Bao Y,
    5. Guérin A,
    6. Yang H,
    7. et al.

    Sleep quality and other patient-reported outcomes improve after patients with psoriasis with suboptimal response to other systemic therapies are switched to adalimumab: results from PROGRESS, an open-label Phase IIIB trial. Br J Dermatol 2012;167:1374–81.

    OpenUrlCrossRefPubMed
12. 12.↵
    1. Gezer O,
    2. Batmaz İ,
    3. Sariyildiz MA,
    4. Sula B,
    5. Ucmak D,
    6. Bozkurt M,
    7. et al.

    Sleep quality in patients with psoriatic arthritis. Int J Rheum Dis 2014 Nov 1 (E-pub ahead of print).
13. 13.↵
    1. Malik SW,
    2. Kaplan J

    . Sleep deprivation. Prim Care 2005;32:475–90.

    OpenUrlPubMed
14. 14.↵
    1. Gangwisch JE,
    2. Heymsfield SB,
    3. Boden-Albala B,
    4. Buijs RM,
    5. Kreier F,
    6. Pickering TG,
    7. et al.

    Sleep duration as a risk factor for diabetes incidence in a large US sample. Sleep 2007;30:1667–73.

    OpenUrlPubMed
15. 15.↵
    1. Kono M,
    2. Tatsumi K,
    3. Saibara T,
    4. Nakamura A,
    5. Tanabe N,
    6. Takiguchi Y,
    7. et al.

    Obstructive sleep apnea syndrome is associated with some components of metabolic syndrome. Chest 2007;131:1387–92.

    OpenUrlCrossRefPubMed
16. 16.↵
    1. Buscemi D,
    2. Kumar A,
    3. Nugent R,
    4. Nugent K

    . Short sleep times predict obesity in internal medicine clinic patients. J Clin Sleep Med 2007;3:681–8.

    OpenUrlPubMed
17. 17.↵
    1. Gangwisch JE,
    2. Malaspina D,
    3. Boden-Albala B,
    4. Heymsfield SB

    . Inadequate sleep as a risk factor for obesity: analyses of the NHANES I. Sleep 2005;28:1289–96.

    OpenUrlPubMed
18. 18.↵
    1. Thorburn PT,
    2. Riha RL

    . Skin disorders and sleep in adults: where is the evidence? Sleep Med Rev 2010;14:351–8.

    OpenUrlCrossRefPubMed
19. 19.↵
    1. Henry AL,
    2. Kyle SD,
    3. Bhandari S,
    4. Chisholm A,
    5. Griffiths CE,
    6. Bundy C

    . Measurement, classification and evaluation of sleep disturbance in psoriasis: a systematic review. PLoS One 2016;11:e0157843.

    OpenUrl
20. 20.↵
    1. Taylor W,
    2. Gladman D,
    3. Helliwell P,
    4. Marchesoni A,
    5. Mease P,
    6. Mielants H,
    7. et al.

    Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum 2006;54:2665–73.

    OpenUrlCrossRefPubMed
21. 21.↵
    1. Gladman DD,
    2. Chandran V

    . Observational cohort studies: lessons learnt from the University of Toronto Psoriatic Arthritis Program. Rheumatology 2011;50:25–31.

    OpenUrlCrossRefPubMed
22. 22.↵
    1. Buysse DJ,
    2. Reynolds CF,
    3. Monk TH,
    4. Berman SR,
    5. Kupfer DJ

    . The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res 1989;28:193–213.

    OpenUrlCrossRefPubMed
23. 23.↵
    1. Gladman DD,
    2. Shuckett R,
    3. Russell ML,
    4. Thorne JC,
    5. Schachter RK

    . Psoriatic arthritis (PSA)—an analysis of 220 patients. Q J Med 1987;62:127–41.

    OpenUrlPubMed
24. 24.↵
    1. Marks R,
    2. Barton SP,
    3. Shuttleworth D,
    4. Finlay AY

    . Assessment of disease progress in psoriasis. Arch Dermatol 1989;125:235–40.

    OpenUrlCrossRefPubMed
25. 25.↵
    1. MacKenzie H,
    2. Thavaneswaran A,
    3. Chandran V,
    4. Gladman DD

    . Patient-reported outcome in psoriatic arthritis: a comparison of Web-based versus paper-completed questionnaires. J Rheumatol 2011;38:2619–24.

    OpenUrlAbstract/FREE Full Text
26. 26.↵
    1. Blackmore MG,
    2. Gladman DD,
    3. Husted J,
    4. Long JA,
    5. Farewell VT

    . Measuring health status in psoriatic arthritis: the Health Assessment Questionnaire and its modification. J Rheumatol 1995;22:886–93.

    OpenUrlPubMed
27. 27.↵
    1. Husted JA,
    2. Gladman DD,
    3. Farewell VT,
    4. Long JA,
    5. Cook RJ

    . Validating the SF-36 health survey questionnaire in patients with psoriatic arthritis. J Rheumatol 1997;24:511–7.

    OpenUrlPubMed
28. 28.↵
    1. Sokoll KB,
    2. Helliwell PS

    . Comparison of disability and quality of life in rheumatoid and psoriatic arthritis. J Rheumatol 2001;28:1842–6.

    OpenUrlAbstract/FREE Full Text
29. 29.↵
    1. Ware JE,
    2. Sherbourne CD

    . The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992;30:473–83.

    OpenUrlCrossRefPubMed
30. 30.↵
    1. Chandran V,
    2. Bhella S,
    3. Schentag C,
    4. Gladman DD

    . Functional Assessment of Chronic Illness Therapy–Fatigue Scale is valid in patients with psoriatic arthritis. Ann Rheum Dis 2007;66:936–9.

    OpenUrlAbstract/FREE Full Text
31. 31.↵
    1. Mease PJ

    . Measures of psoriatic arthritis: Tender and Swollen Joint Assessment, Psoriasis Area and Severity Index (PASI), Nail Psoriasis Severity Index (NAPSI), Modified Nail Psoriasis Severity Index (mNAPSI), Mander/Newcastle Enthesitis Index (MEI), Leeds Enthesitis Index (LEI), Spondyloarthritis Research Consortium of Canada (SPARCC), Maastricht Ankylosing Spondylitis Enthesis Score (MASES), Leeds Dactylitis Index (LDI), Patient Global for Psoriatic Arthritis, Dermatology Life Quality Index (DLQI), Psoriatic Arthritis Quality of Life (PsAQOL), Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT-F), Psoriatic Arthritis Response Criteria (PsARC), Psoriatic Arthritis Joint Activity Index (PsAJAI), Disease Activity in Psoriatic Arthritis (DAPSA), and Composite Psoriatic Disease Activity Index (CPDAI). Arthritis Care Res 2011;63Suppl 11:S64–85.

    OpenUrlCrossRef
32. 32.↵
    1. Yang Y,
    2. Brazier J,
    3. Longworth L

    . EQ-5D in skin conditions: an assessment of validity and responsiveness. Eur J Health Econ 2015;16:927–39.

    OpenUrl
33. 33.↵
    1. Carneiro C,
    2. Chaves M,
    3. Verardino G,
    4. Drummond A,
    5. Ramos-e-Silva M,
    6. Carneiro S

    . Fatigue in psoriasis with arthritis. Skinmed 2011;9:34–7.

    OpenUrlPubMed
34. 34.↵
    1. McDonough E,
    2. Ayearst R,
    3. Eder L,
    4. Chandran V,
    5. Rosen CF,
    6. Thavaneswaran A,
    7. et al.

    Depression and anxiety in psoriatic disease: prevalence and associated factors. J Rheumatol 2014;41:887–96.

    OpenUrlAbstract/FREE Full Text
35. 35.↵
    1. Lee M,
    2. Choh AC,
    3. Demerath EW,
    4. Knutson KL,
    5. Duren DL,
    6. Sherwood RJ,
    7. et al.

    Sleep disturbance in relation to health-related quality of life in adults: the Fels Longitudinal Study. J Nutr Health Aging 2009;13:576–83.

    OpenUrlCrossRefPubMed
36. 36.↵
    1. Brown G,
    2. Malakouti M,
    3. Wang E,
    4. Koo JY,
    5. Levin E

    . Anti-IL-17 phase II data for psoriasis: A review. J Dermatol Treat 2015;26:32–6.

    OpenUrl
37. 37.↵
    1. Gowda S,
    2. Goldblum OM,
    3. McCall WV,
    4. Feldman SR

    . Factors affecting sleep quality in patients with psoriasis. J Am Acad Dermatol 2010;63:114–23.

    OpenUrlCrossRefPubMed
38. 38.↵
    1. Magrey MN,
    2. Antonelli M,
    3. James N,
    4. Khan MA

    . High frequency of fibromyalgia in patients with psoriatic arthritis: a pilot study. Arthritis 2013;2013:762921.

    OpenUrlPubMed
39. 39.↵
    1. Cheng P,
    2. Drake C

    . Occupational sleep medicine. Sleep Med Clin 2016;11:65–79.

    OpenUrl
40. 40.↵
    1. Walsh JA,
    2. McFadden ML,
    3. Morgan MD,
    4. Sawitzke AD,
    5. Duffin KC,
    6. Krueger GG,
    7. et al.

    Work productivity loss and fatigue in psoriatic arthritis. J Rheumatol 2014;41:1670–4.

    OpenUrlAbstract/FREE Full Text